Eterna Therapeutics
ERNA
7 hedge funds and large institutions have $7.63M invested in Eterna Therapeutics in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
4% less capital invested
Capital invested by funds: $7.92M → $7.63M (-$292K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$354K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18K |
ERNA Hedge Fund Activity: Q1 2015 in Review
7 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2015, worth a combined $7.63M — down 3.7% from $7.92M a quarter earlier.
Fund positioning in ERNA was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was AWM Investment Company, adding an estimated $354K. The largest seller was Citadel Advisors, cutting an estimated $18K.
- 7 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $7.63M of Eterna Therapeutics stock for Q1 2015, down 3.7% quarter-over-quarter.
- 0 funds opened new Eterna Therapeutics positions in Q1 2015 and 0 closed out.
- The largest Eterna Therapeutics buyer in Q1 2015 was AWM Investment Company, an estimated $354K added.
- The largest Eterna Therapeutics seller in Q1 2015 was Citadel Advisors, an estimated $18K sold.
Based on aggregated 13F filings for Q1 2015.